Director, HCP & Patient Marketing, Therapeutic Oncology Biosimilars


The Biosimilars Therapeutic Portfolio Director of HCP & Patient Marketing will be responsible for strategy development and tactical execution of personal and non-personal promotion to healthcare professionals, payersand patients. Products in scope for this role include RUXIENCE (rituximab biosimilar), ZIRABEV (bevacizumab biosimilar) and Trazimera (trastuzumab biosimilar).

This role will report to the US Franchise Lead, Oncology Biosimilars and will interface extensively with cross-functional partners within PCAand the Oncology Business Unit. The mAb Oncology Biosimilars portfolio is on track to exceed operating plan and is well positioned to continue growth in the years to come.

This position requires strong strategic, analytical and execution skills, interpersonal and communication skills and agility to learn and work across multiple stakeholders. This individual needs to be a self-starter with ability to manage multiple priorities, has attention to detail and can lead and collaborate across the enterprise. Finally, the position will require flexibility and an ability to act with urgency given the fast-moving nature of this field.

  • Identify, develop, and lead execution of strategies and tactics to maximize growth trajectory for a portfolio of three products that launched simultaneously in early 2020.
  • Lead development of promotional materials for HCPs and patients including value proposition, product positioning and messaging.
  • Work in close collaboration with value marketing, and pricing leads to execute "cost & coverage" strategies and tactics
  • Partner with Global biosimilars team to drive efficiencies byleveraging learnings and insights
  • Lead short and long-term strategic planning for theBiosimilars mAb oncology portfolio
  • Assess growth levers for mAb Oncology biosimilars across all stakeholders (HCP, patient, payer/GPO, key accounts, advocacy)
  • Transform relevant customer insights into commercial output and development and execution of key initiatives
  • Explore differentiation opportunities to create sustainable value for customers for the portfolio
  • Work with analytics colleagues to understand performance trends, identify opportunities for the portfolio. Develop and monitor key metrics to evaluate the portfolio initiatives and make relevant adjustments
  • Partner with PGS colleagues to ensure supply continuity for Portfolio
  • Collaborate closely with PCA colleagues to identify optimal payer strategy and ensure patient access to the biosimilar portfolio and generate demand
  • Coordinate and align biosimilar related work across cross-functional and marketing colleagues, agencies, and other stakeholders to ensure strategic and tactical alignment and execution
  • Act as global point of contact for the mAB Oncology portfolio related items and resolution of key issues and champion GLocal working model.
  • Present recommendations to senior leadership on and represent Team on various internal and external leadership venues and engagements on biosimilar related topics
  • Develop creative and strategic insights about customer needs through collaboration with medical, market analytics and sales colleagues as well as directly with HCPs
  • Plan, synthesize and evaluate market research to identify and address opportunities and gaps
  • Identify market opportunities and competitive threats; prioritize activities to address competitive threats
  • Oversee strategic initiatives requiring the contributions of internal and external colleagues, agencies and partners
  • Develop presentations for management and internal stakeholders on brand priorities, opportunities, and threats; lead development of Tactical Plans and Operating Plans
  • Seek and apply knowledge about the dynamic framework of legal-regulatory requirements to meet customer needs while remaining compliant
  • Collaborate closely with sales leadership, training, RC and others to develop and deliver sales training
  • Lead agency interactions to build brand platform and develop HCP and patient promotional materials
  • Manage OPEX budget up to $10 M
  • Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

  • 10+ years pharmaceutical marketing experience and strong knowledge of the pharmaceutical marketplace are essential. Bachelor's degree required.
  • Proven ability to:
  • generate deep, targeted customer insights and integrate into business decisions,
  • identify and capture cross-brand and cross-customer synergies,
  • operate in both functional and brand environment,
  • balance short and long term priorities,
  • demonstrate initiative, strong strategic and leadership skills,
  • apply analytical and strategic thinking,
  • translate strategy and analysis to a tactical, executable level,
  • synthesize complex information and distill critical customer driven insights to drive brand performance,
  • work effectively in a customer and brand team-based environment and partner with internal and external stakeholders,
  • problem-solve and make decisions,
  • project manage complex workstreams,
  • apply verbal and written communication skills, and manage multiple priorities effectively.

  • MBA preferred.
  • Experience working on Medicare Part B products and/or developing "cost and coverage" messaging for HCPs also preferred.



Business analytics and insights, finance, medical affairs, payer marketing, sales, corporate affairs, legal, global commercial team, PGS and regulatory. No direct reports; agency and consultant supervision required


Manage agency budget, up to $10M for the portfolio


25% travel required

Additional Job Details:
Last Date to Apply for Job: October 30, 2021

Additional Locations: NYC, Peapack, NJ or Lake Forest, IL
Eligible for relocation package: Yes
Eligible for Employee Referral Bonus: Yes


Pfizer requires all U.S. new hires to be fully vaccinated for COVID-19 prior to the first date of employment. As required by applicable law, Pfizer will consider requests for Reasonable Accommodations.

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.

Marketing and Market Research